Sign In
Buy CMXC
$0.0220
+0 (+0%)
At Close: Mar 15, 2023
StimCell Energetics Inc. (Formerly "Cell MedX Corp.") Announces Major Corporate Updates and Rebranding
01:30pm, Monday, 04'th Nov 2024
VANCOUVER, BC / ACCESSWIRE / November 4, 2024 / StimCell Energetics Inc. (formerly "Cell MedX Corp.") (OTC PINK:CMXC) ("StimCell", or the "Company") a biotech company targeting cellular energy to prom
Cell MedX Corp. Closes Private Placement Financing
01:28pm, Tuesday, 19'th Mar 2024
Vancouver, British Columbia--(Newsfile Corp. - March 19, 2024) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX", or the "Company") a biotech company focusing on the discovery, development and commercia
Cell MedX Corp. Announces Resignation of Director
04:47pm, Wednesday, 28'th Feb 2024
Vancouver, British Columbia--(Newsfile Corp. - February 28, 2024) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX", or the "Company") a biotech company focusing on the discovery, development and commer
Cell MedX Corp. Appoints Dr. George Adams as Chairman of the Board
09:15am, Monday, 26'th Feb 2024
Vancouver, British Columbia--(Newsfile Corp. - February 26, 2024) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX", or the "Company") a biotech company focusing on the discovery, development and commer
Cell MedX Corp. Announces New CEO and Directors and Debt Settlement
02:24pm, Tuesday, 19'th Dec 2023
Vancouver, British Columbia--(Newsfile Corp. - December 19, 2023) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commer
Cell MedX Corp. Announces Full Revocation of British Columbia Cease Trade Order
01:16pm, Monday, 27'th Nov 2023
Vancouver, British Columbia--(Newsfile Corp. - November 27, 2023) - Cell MedX Corp. ("Cell MedX" or the "Company") (OTC Pink: CMXC) announces that on November 22, 2023, the British Columbia Securities
Cell MedX Corp. Appoints Audit Committee and Accepts Resignation of Chief Operating Officer
08:00am, Thursday, 09'th Nov 2023
Vancouver, British Columbia--(Newsfile Corp. - November 9, 2023) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commerc
Cell MedX Corp: FDA Commences Review of Cell MedX''s Premarket Notification (510K) and Health Canada Renews Class II Medical Device Licenses for eBalance(R) Systems
01:32pm, Monday, 15'th Nov 2021 FinanzNachrichten
Carson City, Nevada--(Newsfile Corp. - November 15, 2021) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercializa
